NAD+ IV

A physician-supervised intravenous infusion of nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in cellular energy production and DNA repair. The session runs 60 to 90 minutes with careful drip-rate management to minimise discomfort, preceded by a medical consultation to confirm suitability and individualise the protocol under FMH-certified medical oversight.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell, playing a central role in mitochondrial energy production, DNA repair mechanisms, and the regulation of sirtuins — a family of proteins associated with cellular ageing processes. NAD+ levels naturally decline with age, and research suggests that this decline may contribute to reduced cellular energy output, impaired repair capacity, and various age-related physiological changes. The NAD+ IV at ivilounge delivers this coenzyme directly into the bloodstream, bypassing the digestive system where oral NAD+ precursors (such as NMN or NR) undergo metabolic conversion with variable efficiency. Intravenous delivery provides the molecule in its active form, allowing for higher plasma concentrations than are typically achievable through oral supplementation. The infusion is administered slowly over 60 to 90 minutes. NAD+ drips require careful rate management because rapid infusion may cause temporary side effects such as chest tightness, nausea, or flushing. The supervising FMH-certified physician adjusts the drip rate based on the client's tolerance and response, ensuring the session remains comfortable throughout. Prior to the infusion, a medical consultation assesses the client's health status, current medications, and treatment goals. NAD+ IV therapy is contraindicated in certain conditions, and the pre-screening ensures the protocol is appropriate for the individual. Clients commonly report improved mental clarity, sustained energy, and a general sense of wellbeing in the days following NAD+ infusions, though individual responses vary. The therapy is popular among those interested in longevity-focused wellness, individuals experiencing fatigue or cognitive fog, and people seeking support during periods of high physical or mental demand. NAD+ IV therapy is an emerging area of wellness medicine. While preclinical research and early clinical observations are encouraging, it is important to note that large-scale clinical trials are still in progress. The treatment is offered as a wellness support intervention, not as a cure or treatment for any specific disease.